MedTrace Logo

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

NCT05324683 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-03-27

No results posted yet for this study

Summary

The study aims to assess contemporary practice in OCT use during routine interven-tional practice and to assess the impact of the MLD-MAX algorithm on real-world PCI in a large unselected European all-comer-study cohort.

Conditions

  • Myocardial Ischemia

Interventions

OTHER

No intervention planned

No intervention planned; study is observational

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • IHF GmbH - Institut für Herzinfarktforschung

    lead OTHER

Principal Investigators

  • David-Manuel Leistner, Prof Dr med · Universitätsklinikum Frankfurt - Med. Klinik 3 - Kardiologie

  • Thomas Johnson, Dr med · Bristol Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05324683 on ClinicalTrials.gov